Insulin Signaling Pathways Regulating PKCBeta Splicing

调节 PKCβ 剪接的胰岛素信号通路

基本信息

  • 批准号:
    8038449
  • 负责人:
  • 金额:
    $ 27.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-08-15 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alternative splicing of pre-mRNA transcripts is a widespread means for producing polypeptide diversity from a single gene. Over 60% of human genes are expressed through alternative splicing, however, mechanisms of splicing regulation are poorly understood. This lab discovered that insulin regulates the alternative splicing of protein kinase C-(II (PKC(II) in its target tissues: muscle, fat, liver and in cells with functional insulin receptor such as aortic smooth muscle cells, embryonic fibroblasts, and HeLa cells. We identified members of the Serine/Arginine-rich (SR) family splicing proteins that bind to splicing enhancers in the pre-mRNA to regulate exon inclusion as the factors phosphorylated in response to insulin. We first studied SRp40, a splicing enhancer and identified Akt as a kinase that regulated its function via phosphorylation of residues in the arginine/serine (RS) domain. We hypothesize that Akt acts as a molecular switch in splicing regulation at several steps by also regulating other SR protein kinases such as Clk, a family of four dual function LAMMER kinases. Kinases such as Clk1 (also called Clk/Sty) and Clk2 phosphorylate SR proteins and alter their interactions in the spliceosome. Unraveling how Akt regulates Clk will add another level of regulation to insulin action. The long-term goal of the research is to determine how insulin regulates nuclear splice site selection via the activation of various kinases and splicing factors. The current aims will investigate (1) the roles of Clk1 and Clk2 phosphorylation in PKC( alternative splicing, (2) determine how SRp55 functions in PKC( splicing, and (3) identify spliceosome complexes involved in the insulin activated spliceosome and depletion of splicing factors from nuclear extracts using in vitro splicing assays to define cis-elements involved in insulin regulated splicing. The discovery that insulin regulates splicing of PKC(II, a kinase involved in insulin responses at multiple levels, indicates that there are also other target genes of this pathway that must also be spliced in a similar manner. The unique system will reveal the nature of kinase regulation, focusing on PKC(II in splicing and diabetes. PUBLIC HEALTH RELEVANCE Given the magnitude of the problems encountered with diabetes and its complications, understanding insulin action has an immense impact on healthcare since it is the sixth leading cause of disease-related death in the US. The need to define the factors contributing to diabetes onset and identify new potential therapeutic targets is a priority. The processing of pre-mRNA following insulin stimulation of its target tissues is a poorly understood area that is altered in the diabetic state. Understanding the insulin receptor signaling pathways with the goal of defining how insulin action is reflected in the nucleus of insulin responsive tissues will allow us to determine the specificity of signaling through the insulin receptor to regulate metabolic functions causing resistance to insulin action. This proposal is designed to investigate a new kinase in the insulin signaling cascade, Clk/Sty, and its nuclear substrates, SR proteins, which modify RNA processing to alter gene expression. SR proteins are altered in insulin resistance.
描述(由申请人提供):前MRNA转录本的替代剪接是从单个基因产生多肽多样性的普遍手段。超过60%的人类基因是通过替代剪接表达的,但是,剪接调节的机制知之甚少。 This lab discovered that insulin regulates the alternative splicing of protein kinase C-(II (PKC(II) in its target tissues: muscle, fat, liver and in cells with functional insulin receptor such as aortic smooth muscle cells, embryonic fibroblasts, and HeLa cells. We identified members of the Serine/Arginine-rich (SR) family splicing proteins that bind to splicing enhancers in前MRNA调节外显子纳入胰岛素的磷酸化,我们首先研究了SRP40,这是一种剪接增强子,并确定AKT是一种激酶,通过在精液/丝氨酸(RS)域中通过SPITIC进行了SPICER的STRICTARTIAL STICALS SCHOTIEL SCORTULTAR SCTICTS SCOTCONT SCHOTIONT AKT磷酸化。蛋白质激酶,例如四个双重功能板酶的家族,例如CLK1(也称为CLK/sty)和CLK2磷酸化的SR蛋白质,并改变其在剪接中的相互作用。激酶和剪接因子。胰岛素调节胰岛素的胰岛素调节pkc的发现(ii,在多个级别的胰岛素反应中涉及的激酶)表明,该途径的其他目标基因也必须以类似的方式固定该途径。独特的系统将透露Kinase posies tabice and compoy,ii neverboy compoties emplice everys的链接。胰岛素调节PKC的剪接(ii,在多个级别上涉及胰岛素反应的激酶,表明该途径的其他靶基因也必须以类似的方式固定该途径。糖尿病及其并发症的问题对医疗保健有很大的影响,因为这是美国与疾病相关的第六个主要原因胰岛素受体信号传导途径的目的是确定胰岛素反应性组织核中如何反映胰岛素作用,这使我们能够通过胰岛素受体来确定信号传导的特异性,以调节该胰岛素的抑制作用,以调节胰岛素的新动力酶,并构成了胰岛素casce casce/clkk/clkk/clkk casce casce case/clkk/clkk/ RNA处理以改变基因表达。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The protein kinase C beta II exon confers mRNA instability in the presence of high glucose concentrations.
蛋白激酶 C beta II 外显子在高葡萄糖浓度下导致 mRNA 不稳定。
  • DOI:
    10.1074/jbc.m206797200
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Patel,NiketaA;Eichler,DuaneC;Chappell,DavidS;Illingworth,PhilipA;Chalfant,CharlesE;Yamamoto,Mayumi;Dean,NicholasM;Wyatt,JacquelineR;Mebert,Konrad;Watson,JamesE;Cooper,DeniseR
  • 通讯作者:
    Cooper,DeniseR
PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells.
  • DOI:
    10.3727/000000006783991890
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Patel NA;Song SS;Cooper DR
  • 通讯作者:
    Cooper DR
Phosphoinositide 3-kinase mediates protein kinase C beta II mRNA destabilization in rat A10 smooth muscle cell cultures exposed to high glucose.
在暴露于高葡萄糖的大鼠 A10 平滑肌细胞培养物中,磷酸肌醇 3-激酶介导蛋白激酶 C beta II mRNA 不稳定。
  • DOI:
    10.1016/s0003-9861(02)00208-4
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Patel,NiketaA;Yamamoto,Mayumi;Illingworth,Philip;Mancu,Daniel;Mebert,Konrad;Chappell,DavidS;Watson,JamesE;Cooper,DeniseR
  • 通讯作者:
    Cooper,DeniseR
Insulin regulates protein kinase CbetaII alternative splicing in multiple target tissues: development of a hormonally responsive heterologous minigene.
胰岛素调节多个靶组织中的蛋白激酶 CbetaII 选择性剪接:激素响应异源小基因的发育。
  • DOI:
    10.1210/me.2003-0391
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Patel,NiketaA;Apostolatos,HerculesS;Mebert,Konrad;Chalfant,CharlesE;Watson,JamesE;Pillay,TS;Sparks,Janet;Cooper,DeniseR
  • 通讯作者:
    Cooper,DeniseR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENISE Ratzlaff COOPER其他文献

DENISE Ratzlaff COOPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENISE Ratzlaff COOPER', 18)}}的其他基金

Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomes
人脂肪细胞来源的干细胞外泌体治疗缺血性伤口的机制
  • 批准号:
    9349163
  • 财政年份:
    2017
  • 资助金额:
    $ 27.79万
  • 项目类别:
Mechanisms for treating ischemic wounds with human adipocyte derived stem cell exosomes
人脂肪细胞来源的干细胞外泌体治疗缺血性伤口的机制
  • 批准号:
    9898296
  • 财政年份:
    2017
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    8012334
  • 财政年份:
    2010
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6704151
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6914129
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7778227
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7466756
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin Signaling Pathways Regulating PKCBeta Splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    7871748
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin signaling pathways regulating PKCBeta splicing
调节 PKCβ 剪接的胰岛素信号通路
  • 批准号:
    6792651
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:
Insulin signaling pathways regulating PKC beta splicing
调节 PKC β 剪接的胰岛素信号通路
  • 批准号:
    6382861
  • 财政年份:
    2001
  • 资助金额:
    $ 27.79万
  • 项目类别:

相似国自然基金

3'-甲氧基葛根素生物合成途径中关键甲基转移酶基因的克隆与功能分析
  • 批准号:
    31300258
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
  • 批准号:
    81300507
  • 批准年份:
    2013
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
3'-UTR单核苷酸多态性影响CYP8B1基因表达致胆囊胆固醇结石形成的机制研究
  • 批准号:
    81370561
  • 批准年份:
    2013
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
异源杂交多倍化鲫鲤特有性状的转录组及后转录组水平变化规律研究
  • 批准号:
    31360514
  • 批准年份:
    2013
  • 资助金额:
    54.0 万元
  • 项目类别:
    地区科学基金项目
HIF基因3'UTR区SNP参与胰腺癌HIF-1α表达调控的分子机制及功能研究
  • 批准号:
    81302082
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了